Salveen Richter
Stock Analyst at Roth Capital
(3.11)
# 1,220
Out of 4,959 analysts
194
Total ratings
41.82%
Success rate
1.94%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $7.00 | +442.86% | 5 | Aug 12, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Neutral | $10 → $19 | $19.77 | -3.89% | 6 | Aug 7, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Sell | $15 → $17 | $24.79 | -31.41% | 9 | Aug 7, 2025 | |
| ELVN Enliven Therapeutics | Initiates: Buy | $37 | $19.86 | +86.30% | 1 | Jun 16, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Neutral | $53 → $47 | $52.95 | -11.24% | 4 | May 8, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $15 → $13 | $10.53 | +23.46% | 3 | May 8, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $124 → $104 | $58.02 | +79.25% | 1 | May 5, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $37 → $41 | $25.94 | +58.06% | 2 | May 2, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $12 → $9 | $7.66 | +17.57% | 2 | May 2, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $9 → $10 | $12.65 | -20.95% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $601.00 | +33.78% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $140.16 | +40.55% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $36 → $32 | $27.82 | +15.03% | 8 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $3.50 | +414.29% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $117.10 | -18.02% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $99 → $51 | $26.58 | +91.87% | 10 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $15.31 | +161.27% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $10.17 | +17.99% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $20 | $15.85 | +26.22% | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $86.98 | -19.52% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $198 → $370 | $467.55 | -20.86% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $29.65 | +156.32% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $33 → $37 | $43.53 | -14.99% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $38.25 | +38.56% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $295.75 | +18.34% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $400.27 | +39.66% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $18.40 | -72.83% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.15 | +2,595.65% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $285.27 | -21.13% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.29 | +568.69% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.65 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.74 | +532.91% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $4.86 | +85.38% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $2.88 | +4.17% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $3.67 | +63.49% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $59.57 | -27.82% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $2.78 | -28.06% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $11.91 | +739.63% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $7.40 | +8,008.11% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $98.89 | -49.44% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $20.83 | +116.03% | 1 | Mar 17, 2020 |
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $7.00
Upside: +442.86%
Sarepta Therapeutics
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $19.77
Upside: -3.89%
ACADIA Pharmaceuticals
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $24.79
Upside: -31.41%
Enliven Therapeutics
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $19.86
Upside: +86.30%
CRISPR Therapeutics AG
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $52.95
Upside: -11.24%
Arcus Biosciences
May 8, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $10.53
Upside: +23.46%
BioMarin Pharmaceutical
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $58.02
Upside: +79.25%
Summit Therapeutics
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $25.94
Upside: +58.06%
Amicus Therapeutics
May 2, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $7.66
Upside: +17.57%
Adaptive Biotechnologies
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $12.65
Upside: -20.95%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $601.00
Upside: +33.78%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $140.16
Upside: +40.55%
Mar 3, 2025
Maintains: Neutral
Price Target: $36 → $32
Current: $27.82
Upside: +15.03%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $3.50
Upside: +414.29%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $117.10
Upside: -18.02%
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $26.58
Upside: +91.87%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $15.31
Upside: +161.27%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $10.17
Upside: +17.99%
Dec 12, 2024
Maintains: Neutral
Price Target: $9 → $20
Current: $15.85
Upside: +26.22%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $86.98
Upside: -19.52%
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $467.55
Upside: -20.86%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $29.65
Upside: +156.32%
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $43.53
Upside: -14.99%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $38.25
Upside: +38.56%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $295.75
Upside: +18.34%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $400.27
Upside: +39.66%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $18.40
Upside: -72.83%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.15
Upside: +2,595.65%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $285.27
Upside: -21.13%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.29
Upside: +568.69%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $10.65
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.74
Upside: +532.91%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $4.86
Upside: +85.38%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $2.88
Upside: +4.17%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $3.67
Upside: +63.49%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $59.57
Upside: -27.82%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $2.78
Upside: -28.06%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $11.91
Upside: +739.63%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $7.40
Upside: +8,008.11%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $98.89
Upside: -49.44%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $20.83
Upside: +116.03%